PSMD8 Antibodies

Santa Cruz Biotechnology delivers a wide array of PSMD8 monoclonal antibodies for research focused on understanding PSMD8 protein functions. PSMD8 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PSMD8, also known as the 26S proteasome non-ATPase regulatory subunit 8, plays a critical role in the ubiquitin-proteasome pathway, which is essential for protein degradation and regulation of cellular processes. PSMD8 is involved in maintaining cellular homeostasis and modulating various signaling pathways, making it significant in cancer research and other diseases. Understanding PSMD8 functions can provide insights into the mechanisms of proteostasis and potential therapeutic targets for various conditions. Researchers can explore PSMD8's role in different cellular pathways and disease mechanisms using specific detection methods. Advanced research techniques allow for detailed examination of PSMD8 expression patterns and interactions. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of PSMD8 and its implications in human health and disease.